Erin Silver, MPH , Boyle Silver & Weist Policy Strategists, www.rbwpolicy.com 

Colorado Office of Economic Development & International Trade Now Excepting Applications for 2011 Governor’s Award for Excellence in Exporting 

BOULDER — A handful of area biotechnology firms are moving full steam ahead, bucking a national trend that has seen many cash-strapped companies in the field close down for lack of funding.

Those companies include Boulder-based AmideBio LLC, which is creating new, natural material which could revolutionize Alzheimer's research. Boulder-based miRagen Therapeutics Inc. recently received a key U.S. Food and Drug Administration approval for a drug to regulate blood cell development. And Boulder-based InDevR Inc. saw its virus research published in an important industry journal.

More than 80 bioscience companies large and small are located in the Boulder Valley, according to the Colorado BioScience Association. Of those, 35 are biotech/pharmaceutical companies, 40 are medical device companies, and at least four are biofuel companies. Bioscience workers make an average salary of $74,000, according to state statistics.  

Treatment Targets Alzheimer's Symptoms with Non-Invasive, Non-Drug Device  

Winners announced in UNC Entrepreneurial Challenge  

St. Renatus, LLC (Fort Collins) announced that the company had a favorable End of Phase 2 review with the U.S. Food and Drug Administration (FDA), and agreed that in the near future, the company will proceed with conducting Phase 3 efficacy studies to determine the exact parameters for their nasal mist dental anesthetic achieving dental anesthesia in the maxillary arch.  St. Renatus and the FDA discussed details for both Phase 3 Adult and Pediatric studies to be conducted in the near future. Final revised protocols will be forwarded to the FDA in the coming weeks.  

(Reuters) - Terumo Corp (4543.T) said it would buy U.S. medical device company CaridianBCT from a Swedish firm for about $2.6 billion, marking the largest acquisition by a Japanese medical equipment maker. 

N30 Pharmaceuticals to Present S-Nitrosoglutathione Reductase Inhibitor Preclinical Safety Data at 2011 Society of Toxicology 50th Anniversary Meeting. 

Bioscience Industry Teams with Colorado State University to Create Online Regulatory and Clinical Trial Management Certificate Programs